KR

Kommaboina Rohini

Active Director Director DIN 10923853
DIN 10923853 First appointment Jan 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kommaboina Rohini

Data last updated:

Kommaboina Rohini is a Director at Consia Pharmaceuticals Private Limited (since 2025). The company operates in Healthcare.

DIN 10923853
Primary Designation Director
Industry Healthcare
First Appointment 27 Jan 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jan 20252024Active

Directorship timeline

Open interactive timeline →
Consia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kommaboina Rohini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kommaboina Rohini

Kommaboina Rohini currently holds 1 directorship: Consia Pharmaceuticals Private Limited (Director, since 27 Jan 2025).

Kommaboina Rohini was first appointed on 27 Jan 2025 as Director at Consia Pharmaceuticals Private Limited.

The current boards of Kommaboina Rohini's companies include Katta Geethanjali (Consia Pharmaceuticals Private Limited), Sri Sai Pavana Vihari Uppalapati (Consia Pharmaceuticals Private Limited), Udaya Lakshmi Yama (Consia Pharmaceuticals Private Limited), Uppalapati Anjana (Consia Pharmaceuticals Private Limited), Venkata Sai Harsha Gajula (Consia Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available